Back to Journals » Drug Design, Development and Therapy » Volume 11

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
7,997 Dovepress* 5,204 647+ 695 5,851
PubMed Central* 0 2,146 402 2,146
Totals 5,204 2,793 1,097 7,997
*Since 13 October 2017
+Since July 2016

View citations on PubMed Central and Google Scholar